Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hydgene Renewables Pty Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner and is situated within 1 distinct art unit. This suggests that the company's current patenting activity is focused on a specific technical area with a single point of contact at the patent office.
The busiest examiner, RAMIREZ, DELIA M, is managing 1 busiest examiner pending office action. This single action represents the total 1 pending office action for the company. Effective prosecution will require a strategy that addresses the specific concerns of RAMIREZ, DELIA M within the Biotechnology & Pharmaceuticals sector, taking into account the examiner's previous actions and preferences.
The use of 1 distinct art unit ensures that the examination follows a consistent set of technical standards. Since there is only a single active matter, the company can dedicate its full attention to resolving the issues raised by the 1 distinct examiner. The outcome of the current prosecution is entirely dependent on the interaction with this specific official, making clear communication paramount.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916137 | RECOMBINANT MICROORGANISMS AND PROCESS | RAMIREZ, DELIA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916137 | RECOMBINANT MICROORGANISMS AND PROCESS | RAMIREZ, DELIA M | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17916137 | RECOMBINANT MICROORGANISMS AND PROCESS | RAMIREZ, DELIA M | 1652 | §102§103§112 | Final Rejection | — | Pending | Sep 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHydgene Renewables Pty Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Delia M Ramirez has the most, with 1 of Hydgene Renewables Pty Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
